Total artificial heart: patient selection and risk factors

Affiliations

¹ Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
² Department of Thoracic and CardioVascular Surgery, Thorax Institut, University of Nantes, Nantes, France.

Editorial

Thomas Senage et al. Ann Cardiothorac Surg. 2020 Mar.

. 2020 Mar;9(2):118-120.

doi: 10.21037/acs.2020.02.10.

¹ Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
² Department of Thoracic and CardioVascular Surgery, Thorax Institut, University of Nantes, Nantes, France.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

1. Arabía FA, Cantor RS, Koehl DA, et al. Interagency registry for mechanically assisted circulatory support report on the total artificial heart. J Heart Lung Transplant 2018;37:1304-12. 10.1016/j.healun.2018.04.004 - DOI - PubMed
1. Roussel JC, Baron O, Périgaud C, et al. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality. J Heart Lung Transplant 2008;27:486-93. 10.1016/j.healun.2008.01.019 - DOI - PubMed
1. Fida N, Loebe M, Estep JD, et al. Predictors and management of right heart failure after left ventricular assist device implantation. Methodist Debakey Cardiovasc J 2015;11:18-23. 10.14797/mdcj-11-1-18 - DOI - PMC - PubMed
1. Lima B, Kale P, Gonzalez-Stawinski GV, et al. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device. Am J Cardiol 2016;117:1622-8. 10.1016/j.amjcard.2016.02.038 - DOI - PubMed
1. Remadi JP, Baron O, Roussel JC, et al. Myocardial preservation using celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations. Ann Thorac Surg 2002;73:1495-9. 10.1016/S0003-4975(02)03424-0 - DOI - PubMed